Wedica 50 50 mg Tablet

    Wedica 50 50 mg

    Trelagliptin

    Category: Tablet

    Manufacturer: Beacon Pharmaceuticals Ltd.

    Price: 5038.8

    Box

    Indicated for, type 2 diabetes, when the first line treatment of metformin is not achieving the expected glycemic goals. Hypersensitivity
    Administration: Should be taken once weekly and same day every week. Adult Dose: Oral Adult Tablet One 100mg tablet once weekly Renal Dose: Renal Failure Moderate Creatinine Clearance 30-<50: 50 mg once weekly.
    Hypersensitivity
    Hypoglycemia, nasopharyngitis, elevated lipase. Acute pancreatitis, intestinal obstruction, atrial fibrillation, elevated liver enzyme
    Precaution: Patients with moderate kidney function disease. Hypoadrenalism or Hypopituitarism Malnutrition, irregular eating patterns, starvation Vigorous exercise This drug may cause hypoglycemia when used with other diabetes medication
    It works by inhibiting the activity of dipeptidyl peptidase 4 Trelagliptin inactivates glucagon-like peptide 1 (GLP-1) from secretion from the intestines to the blood via stimulation from oral intake of food, increases GLP-1 blood concentration and promotes blood glucose concentration-dependent insulin secretion from the pancreas.
    Profile avater

    Samm Care